Intestinal (Small Bowel) Cancer: Signs, Types & Treatment in Hyderabad

Intestinal cancer here means cancer of the small intestine (small bowel) — the long, folded tube of duodenum, jejunum and ileum that connects the stomach to the large intestine and absorbs nutrients. It is one of the rarest gastrointestinal cancers and, unusually, comes in several different types. It is distinct from colon and rectal cancer, which affect the large bowel.

It depends on the type and stage. When found early and confined, small bowel cancer is often treatable — and for some types, curable — usually with surgery. More advanced disease is treated with a combination of surgery, chemotherapy and targeted therapy depending on the type. Your outlook depends mainly on the type and stage, which your team explains after tests.

Symptoms are often vague and feel like common tummy problems. The commonest are crampy abdominal pain (often worse after eating), unexplained weight loss, blood in the stool (which may be dark and not visible), nausea or vomiting, and tiredness from a low blood count (anaemia). Sometimes the first sign is a bowel blockage causing severe pain and vomiting. Because the symptoms are non-specific, persistence is the key clue.

Very often, yes — most abdominal symptoms come from common, benign conditions like IBS, gastritis or an ulcer. But symptoms that persist despite treatment, or come with weight loss, bleeding or a low blood count, should be evaluated further — especially as small bowel cancer is easily mistaken for these and is missed by standard scopes.

Possibly. Standard upper endoscopy and colonoscopy do not reach most of the small intestine, so a normal result does not fully rule out small bowel cancer. If symptoms persist, special tests such as capsule endoscopy, deep enteroscopy or CT/MRI enterography can examine the small bowel properly.

The main types are adenocarcinoma, carcinoid (neuroendocrine) tumours, gastrointestinal stromal tumours (GIST) and lymphoma. They behave differently and are treated differently — for example, targeted therapy is central for GIST, while lymphoma is treated mainly with chemotherapy — which is why identifying the type is central to planning care.

Because the small intestine is hard to reach, diagnosis uses special tests: CT or MRI enterography (scans with a special dye), capsule endoscopy (a tiny swallowable camera), deep enteroscopy (a long thin camera), and a biopsy — a small tissue sample that confirms the diagnosis and the type. A PET-CT scan may be used to help stage the cancer. A biopsy is safe and does not spread cancer; it is the only way to be certain.

They are the tests designed to see the small bowel that ordinary scopes miss. Capsule endoscopy is a pill-sized camera you swallow that films the small intestine as it passes through. Deep (balloon) enteroscopy uses a long, thin flexible camera that reaches deep into the small bowel and can take a biopsy. CT/MRI enterography is a scan done after drinking a special contrast that expands and outlines the bowel so a tumour or narrowing shows up. At CION these are coordinated with our gastroenterology colleagues.

Its risk factors are distinctive. They include Crohn’s disease and other inflammatory bowel disease, coeliac disease, inherited conditions such as Lynch syndrome and familial polyps, intestinal polyps, and a diet high in red or processed meat. Having a risk factor does not mean you will develop it — most people never do — but these groups benefit from earlier evaluation of persistent new symptoms.

Yes, both are recognised risk factors for small bowel cancer, which is why long-standing Crohn’s or coeliac disease deserves attention if new, persistent symptoms appear. It is important to keep this in perspective: the great majority of people with Crohn’s or coeliac disease never develop small bowel cancer. If you have either, mention any new or changing symptoms to your doctor so they can be checked early.

Surgery to remove the affected part of the small intestine (a bowel resection) is the main treatment and is often curative when the cancer is caught early. Depending on the type and stage, the team may add chemotherapy, targeted therapy (central for GIST) or, in selected cases, radiation. Because the four types are treated quite differently, a multidisciplinary tumour board confirms the type before finalising the plan.

A small bowel resection is surgery to remove the segment of small intestine containing the tumour, along with a margin of healthy tissue and nearby lymph nodes, after which the healthy ends are reconnected. It is the mainstay of treatment for most small bowel cancers. Because the small intestine is long, removing a section usually leaves enough to absorb nutrients normally.

Often less than people fear. The small intestine is long, and removing a section usually leaves enough to absorb nutrients. Your team and a dietitian support you through any adjustment, and most people eat normally again. The impact depends on how much and which part is removed, which your surgeon explains beforehand.

Usually no. Most small bowel resections simply reconnect the two healthy ends of the intestine, so no stoma is needed. A stoma is uncommon in small bowel cancer surgery and, when it is required, is often temporary. Your surgeon will discuss with you in advance whether a stoma is likely in your case, and stoma-care support is available if it is.

A gastrointestinal stromal tumour (GIST) develops from specialised cells in the wall of the intestine and behaves differently from other small bowel cancers. Treatment usually centres on surgery to remove the tumour, and targeted therapy is often central — either after surgery or for tumours that have spread. Because GIST is managed so specifically, confirming the type on biopsy is essential.

Carcinoid tumours arise from hormone-producing (neuroendocrine) cells and are often slow-growing. Treatment usually centres on surgery to remove the tumour, and in some cases specific medicines are used to control hormone-related symptoms or slow the tumour. As with all small bowel cancers, the plan is tailored to the type and stage by the oncology team.

Cost depends on the type, stage, the surgery, and whether chemotherapy or targeted therapy is needed, so it is best given as an indicative range after assessment. Eligible treatment may be covered under Aarogyasri or PMJAY at empanelled centres, and we help with insurance and EMI. Use the cost estimator on this page for an indicative figure, then request a callback for an accurate estimate.

Yes, for eligible patients. Under Aarogyasri and PMJAY, eligible small bowel cancer treatment may be largely covered at empanelled centres. Our team helps you check eligibility and complete the paperwork, and guides you on private insurance and EMI options if a scheme does not apply.

Intestinal (small bowel) cancer affects the small intestine — the duodenum, jejunum and ileum — whereas colon and rectal cancer affect the large bowel. Small bowel cancer is much rarer, is harder to reach and diagnose (standard colonoscopy does not examine it), and comes in several distinct types. Because of these differences it is scoped and treated separately from colon and rectal cancer, though the specialties overlap.

The outlook depends mainly on the type and the stage at diagnosis — early, confined tumours have much better outcomes than advanced ones, which is why evaluating persistent symptoms matters. As with other cancers, small bowel cancer can sometimes return, so structured follow-up after treatment watches for any recurrence so it can be caught and treated early. Ask your oncologist for outcomes relevant to your specific type, stage and plan.